METHODS FOR IDENTIFYING CHIMERIC ANTIGEN RECEPTOR-TARGETING LIGANDS AND USES THEREOF
Exclusively Licensed
Invention type: Technology
/
Case number: #22227H
The disclosure features chimeric antigen receptor (CAR) ligands, methods for making the same, and immunomodulatory compositions comprising the CAR ligands. The disclosure also features compositions and methods of using the immunomodulatory compositions, for example, to stimulate activation of CAR expressing cells.
Researchers
Darrell J Irvine
/
Benjamin Cossette
/
Leyuan Ma
/
Naveen Mehta
/
Karl Dane Wittrup
Departments: David H Koch Institute for Integrative Cancer Res, Department of Chemical Engineering
Technology Areas: Biotechnology: DNA & RNA Editing / Diagnostics: Assays / Drug Discovery and Research Tools: Cell Interrogation, Genomics & Proteomics / Therapeutics: Cell Based Therapy, Proteins & Antibodies
Impact Areas: Healthy Living
-
methods for identifying chimeric antigen receptor-targeting ligands and uses thereof
United States of America | Published application
License this technology
Interested in this technology? Connect with our experienced licensing team to initiate the process.
Sign up for technology updates
Sign up now to receive the latest updates on cutting-edge technologies and innovations.